TY  - INPR
AV  - public
Y1  - 2021/09/15/
TI  - Impact of a mid-urethral synthetic mesh sling on long-term risk of systemic conditions in women with stress urinary incontinence: a national cohort study
N1  - © 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
UR  - https://doi.org/10.1111/1471-0528.16917
ID  - discovery10135926
N2  - OBJECTIVE: To compare the incidence of systemic conditions between women who had surgical treatment for stress incontinence with mesh and without mesh. DESIGN: National cohort study. SETTING: English National Health Service. POPULATION: Women with no previous record of systemic disease who had first-time urinary incontinence surgery between 1 January 2006 and 31 December 2013, followed up to the earliest of 10 years or 31 March 2019. METHODS: Competing-risks regression was used to estimate hazard ratios (HR), adjusted for patient characteristics, with HR > 1 indicating increased incidence following mesh surgery. MAIN OUTCOME MEASURES: First post-operative admission with a record of autoimmune disease, fibromyalgia or myalgic encephalomyelitis up to 10 years following the first incontinence procedure. Competing-risks regression was used to estimate hazard ratios (HR) of admission, adjusted for patient characteristics, with HR > 1 indicating increased incidence following mesh surgery. RESULTS: The cohort included 88 947 women who had mesh surgery and 3 389 women who had non-mesh surgery. Both treatment groups were similar with respect to age, socio-economic deprivation, comorbidity, and ethnicity. The 10-year cumulative incidence of autoimmune disease, fibromyalgia or myalgic encephalomyelitis was 8.1% (95% confidence interval 7.9% to 8.3%) in the mesh group and 9.0% (8.0% to 10.1%) in the non-mesh group (adjusted HR 0.89 [0.79 to 1.01]; p = 0.07). A sensitivity analysis including only autoimmune diseases as an outcome returned a similar result. CONCLUSIONS: These findings do not support claims that synthetic mesh slings cause systemic disease.
KW  - autoimmune disease
KW  -  colposuspension
KW  -  fascial sling
KW  -  fibromyalgia
KW  -  incontinence surgery
KW  -  midurethral synthetic mesh sling insertion
KW  -  myalgic encephalomyelitis
KW  -  severe adverse events
KW  -  stress urinary incontinence
KW  -  systemic conditions
KW  -  urogynaecology
A1  - Muller, P
A1  - Gurol-Urganci, I
A1  - Thakar, R
A1  - Ehrenstein, MR
A1  - Van Der Meulen, J
A1  - Jha, S
JF  - BJOG: An International Journal of Obstetrics and Gynaecology
ER  -